Mobile technology to boost treatment compliance for asthma patients

The Sun Pharma has rolled out India's first asthma monitoring mobile App, RespiTrack, to connect doctor and patient. Nearly 70 percent asthma patients in India do not adhere to prescribed treatment regimen


Mumbai: As part of its focus to give boost to treatment compliance amongst Asthma patients by minimizing instances of non-adherence and drop-outs in Asthma treatment regime, Sun  Pharma is rolling out, what is calls India’s first unique and innovative mobile application, that will connect doctors and asthma patients. This App has been specifically developed by Sun Pharma for enabling doctors to track treatment progress of their patients and increase compliance to medication for better management of asthma disease.

As per WHO Report, India has an estimated 15-20 million asthmatic patients. Various studies estimate that nearly 40 percent of Asthma patients use inhalers and the rest prefer oral formulations.

It is estimated that nearly 50 percent to 70 percent patients in India do not adhere to asthma treatment regimen recommended by a doctor. Up to 50 percent of such non-adherence is on account of the patient’s forgetfulness to take medicines on time and due to inadequate understanding of the prescribed treatment regimen. Sun Pharma’s RespiTrack aims to address these and other reasons leading to non-adherence thereby improving compliance to Asthma treatment through recurring medication reminders, pre-programmed alerts, Over-the-Air review by the doctor etc.

Commenting on its RespiTrack mobile Application, Mr Abhay Gandhi, CEO – India Business, Sun Pharma said, “Unlike other chronic illnesses where non-adherence to treatment regimen could have significant impact on the patient’s health, Asthmatics tend to be low on the short-run adversity impact of non-adherence. However, in the long run, the implications of non-adherence to prescribed Asthma treatment can severely impede quality of life of these patients. By leveraging our digital technology capabilities, we believe RespiTrack can address this unmet need by reducing non-adherences incidences to treatment.”

For an Asthma patient, RespiTrack allows complete monitoring of asthma attacks, symptoms and medications prescribed by the physician. It enables these patients to record time, place, duration and triggers of attacks along with medication details on the mobile App.
The patient can easily send this data to the  consulting physician through over-the-air mode on a weekly or monthly basis. RespiTrack also offers a review dashboard that gives a snapshot of all parameters to monitor over a period of time.

Through RespiTrack, a doctor can access his patient’s details through a personalized tracker module which is directly synced with the patient’s App. This module allows doctors to access patient’s ailment history, attack patterns, symptoms, medication patterns and reports. A doctor can remotely view patient reports and also connect with them through an integrated messaging app.

Sun Pharma’s RespiTrack is available on Google Play Store and Apple Store. A patient needs a Registration Number issued by his/her doctor to use this App.